Global Novel Drug Delivery Systems (NDDS) Market to Reach $28.1 Billion by 2026

Strategic Insights -

The global market for novel drug delivery systems (NDDS) is expected to experience significant growth, driven by the benefits of controlled-release drug delivery systems, including reduced treatment cost, lower side effects, and enhanced therapeutic efficacy. The adoption of controlled-release drugs is being propelled by the rapidly growing pediatric and geriatric population, who are more prone to non-adherence to prescription drugs. Additionally, the presence of in-vivo biological barriers has created a need for targeted therapy with minimum side effects, making nanocarrier-based systems a promising solution. The market is expected to reach $28.1 billion by 2026, growing at a CAGR of 20.8%.

Key Takeaways:

  • The global NDDS market is expected to reach $28.1 billion by 2026, growing at a CAGR of 20.8%.
  • The market is driven by the benefits of controlled-release drug delivery systems, including reduced treatment cost, lower side effects, and enhanced therapeutic efficacy.
  • The adoption of controlled-release drugs is being propelled by the rapidly growing pediatric and geriatric population.
  • Nanocarrier-based systems are a promising solution for targeted therapy with minimum side effects.
  • The market is expected to be driven by the presence of in-vivo biological barriers that impact the drug's stability, absorption, and bioavailability.
  • The pharmaceutical industry is preparing for the widespread adoption of nanoparticles, which represents a crucial element in advanced nanotechnology-enabled delivery systems.
  • The global market for NDDS was estimated at $9 billion in 2020 and is expected to reach $28.1 billion by 2026.
  • The Nanoparticles segment is expected to grow at a 20.3% CAGR to reach $27.2 billion by the end of the analysis period.
  • The Embolization Particles segment is expected to grow at a 22.9% CAGR for the next 7-year period.
  • The U.S. market is estimated at $4 billion in 2021, while China is forecast to reach $2.9 billion by 2026.
  • The Novel Drug Delivery Systems (NDDS) market in the U.S. is expected to account for a 37.8% share in the global market.

Statistics:

  • The global NDDS market is expected to grow from $9 billion in 2020 to $28.1 billion by 2026, at a CAGR of 20.8%.
  • The Nanoparticles segment is expected to grow at a 20.3% CAGR to reach $27.2 billion by the end of the analysis period.
  • The Embolization Particles segment is expected to grow at a 22.9% CAGR for the next 7-year period.
  • The U.S. market is estimated at $4 billion in 2021, while China is forecast to reach $2.9 billion by 2026.
  • The Novel Drug Delivery Systems (NDDS) market in the U.S. is expected to account for a 37.8% share in the global market.

Sources:

  • "Novel Drug Delivery Systems (NDDS) - Global Market Trajectory & Analytics" by Global Industry Analysts Inc.
  • Global Industry Analysts, Inc. (GIA)
  • StrategyR(TM) Platform
  • MarketGlass(TM) Platform
  • LinkedIn: Global Industry Analysts, Inc.
  • Twitter: @marketbytes